Comprehensive review explores evolving marketing strategies in the pharmaceutical industry, indicating significant changes post-pandemic.
The COVID-19 pandemic significantly transformed the pharmaceutical industry, particularly in marketing strategies. Traditional face-to-face interactions were replaced by digital engagement, reshaping how pharmaceutical companies interact with healthcare professionals (HCPs) and patients. This review explores post-pandemic pharmaceutical marketing trends, including digital transformation, omnichannel marketing, telemedicine integration, data-driven personalization, patient-centric approaches, and regulatory changes. The study synthesizes recent literature to provide insights into evolving marketing strategies and future directions.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: